双歧醋对高脂饮食大鼠血脂影响的机制探讨

目的 探讨双歧醋对高脂饮食大鼠血脂的影响机制.方法 48只SD大鼠被随机分成双歧醋低剂量组[1.8 mL/(kg·BW)]、中剂量组[3.4 mL/(kg· BW)]、高剂量组[6.8 mL/(kg·BW)]和市售醋组[3.4 mL/(kg·BW)]、高脂模型组以及基础对照组,观察双歧醋对高脂饮食大鼠血脂的影响作用机制,测定指标包括大鼠肝脏脂质、大鼠LDLR的免疫组化分析,HMGCoA还原酶和LDLR的RT-PCR分析.结果 双歧醋各组对于HMGCoA还原酶表达有抑制作用,但可以上调LDLR的基因和蛋白质表达.结论 双歧醋可以通过调节HMGCoA还原酶和LDLR的表达预防高脂饮食大鼠高血脂的发生.     

双歧杆菌对高胆固醇饮食小鼠血脂影响的研究

目的了解双歧杆菌对高胆固醇饮食水平异常的动物个体血脂及脂蛋白代谢的影响.方法将高胆固醇饮食小鼠分为2组,一组饮用双歧杆菌菌液,另一组常规饮水.经28 d喂养后,将全部动物处死,并立即取血,取上清液测定血脂及脂蛋白各项指标:血清总胆固醇(TC)、甘油三酯(TG)和高密度脂蛋白(HDL-C).结果高脂饮食 双歧杆菌组TG、TC水平显著低于高脂饮食组(P<0.01),HDL-C/TC显著高于高脂膳食组(P<0.01).结果表明灌胃双歧杆菌,小鼠血清中TC、TG浓度较高脂饮食显著降低(P＜0.01),同时HDL-C浓度有所增加.结论饮用双歧杆菌能显著改善高胆固醇饮食小鼠血脂及脂蛋白代谢状况.     

双歧醋对大鼠预防性减肥的实验研究

目的探讨双歧醋预防大鼠肥胖的作用及相关机制研究。方法 48只SD大鼠被随机分成双歧醋低剂量组[1.8 mL/(kg.BW)]、中剂量组[3.4 mL/(kg.BW)]、高剂量组[6.8 mL/(kg.BW)]和市售醋组[3.4mL/(kg.BW)]、肥胖模型组以及基础对照组,进行预防性减肥实验,观察双歧醋在大鼠肥胖过程中对大鼠的影响,测定指标包括大鼠体重、体脂、Lee’s指数、脂肪细胞直径、血瘦素、血胰岛素。结果实验结果显示,双歧醋各组所有测定指标值都较肥胖组有明显好转,特别是血瘦素和血胰岛素水平,双歧醋的高、中剂量组与市售醋组差异有统计学意义。结论双歧醋能有效预防血瘦素和血胰岛素的升高,预防体脂、Lee’s指数和体重的增加也有一定作用。     

双歧番茄醋的实验研究

目的以番茄为主要原料,对双歧杆菌和醋酸杆菌共同发酵研制双歧番茄醋的工艺进行研究。方法通过正交试验筛选最适工艺。结果双歧番茄醋的最终醋酸度为27 g/L,含双歧杆菌总菌为1.9×1011CFU/mL,5 d内双歧杆菌活菌为5.5×107CFU/mL。双歧番茄醋棕黄色,光泽度好,有成熟番茄香味,入口酸甜适中。结论双歧杆菌与醋酸杆菌在可以番茄汁中共生,此方法制备双歧番茄醋可行。     

双歧醋对常见病原菌的生物拮抗作用研究

目的研究双歧醋对常见病原菌的生物拮抗作用及影响因素。方法采用纸片扩散法(K-B法)、琼脂打孔法和试管稀释法(M IC法)测定双歧醋及其处理物(加热、不同pH)对常见病原菌的拮抗作用,并讨论pH、加热对拮抗作用的影响,同时用某市售醋作为对照。结果双歧醋及其处理物均具有一定的抑菌作用。结论双歧醋对常见病原菌有一定的拮抗作用,抑菌作用强于市售醋。     

功能性双歧醋营养成分分析及保质期观察

目的分析双歧醋的营养成分及保质期观察。方法采用现代多种营养成分分析方法对双歧醋进行主要营养成分的分析测定。结果双歧醋营养丰富,含有多种微量元素,含有18种氨基酸,其中8种人体必需氨基酸含量占总量的42.5%,富含醋酸、乳酸等8种有机酸成分。结论双歧醋营养成分丰富,保质期长,作为一种功能性醋产品值得推广应用。     

用生料制备功能性双歧醋生产工艺的实验室研究

目的将双歧杆菌、醋酸菌、酵母菌和粉碎的制醋原料及麸曲共同发酵,通过生料制醋的方法来制备功能性双歧醋。方法将粉碎的玉米与麸曲、酵母液、麸皮和水搅拌均匀,使其经过液态糖化和酒精发酵后,接入醋酸菌和双歧杆菌(二者比例为1∶1),同时加入辅料,进行醋酸发酵,当检测到醋酸酸度为5.0%~7.5%时,加入食盐终止发酵,经过过滤,除菌澄清得到功能性双歧醋。结果双歧醋的最终醋酸度为3.2%,外观红棕色,光泽度好,清澈透明,无沉淀和悬浮物。总菌数:醋酸菌为3.3×1011/m l,双歧杆菌为1.9×107/m l;活菌数:醋酸菌为1.7×1011/m l,双歧杆菌为6.8×106/m l;大肠菌群数3个/100 m l;致病菌:不得检出。结论双歧杆菌及其代谢物可以在双歧醋中存活,生料固态发酵制备双歧醋的方法可行。     

高脂饮食对雄性SD大鼠肠道菌群的影响

目的探讨通过膳食饲喂高脂饲料诱发的高脂血症大鼠肠道菌群结构的变化。方法 24只SD（Spra-gue Dawley,SD）雄性大鼠随机分为A、B两组,分别连续饲喂基础饲料和高脂饲料42 d,并于第0、9、18、30和42天采集大鼠粪便,应用DGGE（Denaturing gradient gel electrophoresis）和q-PCR技术对肠道菌群进行定性定量分析。结果第42天时A、B组大鼠血清总胆固醇值（TC）分别为（2.01±0.14）mmol/L、（5.16±0.22）mmol/L,B组TC水平较A组明显增高（P〈0.05）。DGGE电泳图谱显示B组42 d时肠道菌群构成较0 d时变化显著,而A组不同时期肠道菌落构成无明显差异。q-PCR定量结果显示,随着饲喂高脂饲料天数的增加,B组小鼠肠道内乳杆菌属和双歧杆菌属较0 d明显降低（P〈0.01）,而拟杆菌门数量呈递减趋势且趋势比较平缓;梭菌属呈递增趋势且增幅相对拟杆菌门的变化较大。结论高脂饮食可导致肠道菌群结构的改变,这种改变会进一步促进高脂血症的形成。     

双歧杆菌复合制剂对脂质代谢的影响

本实验观察了双歧杆菌复合制剂（三株口服液）对高脂血症患者脂质代谢的影响。结果表明,用药第２周血清胆固醇和甘油三酯即开始下降,４周效果明显（Ｐ＜０．０５）,同时高密度脂蛋白也逐渐上升。它说明三株口服液确有改善脂质代谢紊乱的作用。     

泽泻对高脂高糖饮食大鼠肠道菌群多样性的影响

目的研究泽泻对高脂高糖饮食大鼠的降血脂作用与肠道菌群多样性的相关性,并测定高脂高糖饮食大鼠肠道菌群丰度与多样性的变化。方法将32只健康雄性SD大鼠随机分成正常组(control group,CON)、高脂高糖模型组(high-fat and high-sucrose diet group,HFS)、高脂高糖饲料加二甲双胍干预组(metformin treatment group,MET)和高脂高糖饲料加泽泻醇提取物干预组(Alisma orientale extract group,AOE)。每组8只,造模4周后分别灌胃给予相应药物,连续4周。CON组和HFS组灌胃给予生理盐水。检测血清TC、TG、LDL-C及HDL-C水平及其他指标,提取肠道菌群总DNA,分析肠道微生物的变化。结果 HFS组的TC、LDL-C水平明显高于CON组(Ps0.05),给药4周后,AOE组TC、LDL-C水平均显著性降低(Ps0.05)。高通量测序结果显示,AOE组中与脂质代谢、多聚糖生物合成与代谢相关的肠道菌群多样性及丰度增加显著,肠道菌群的生态环境得以改善,形成了新的肠道菌群稳态。结论泽泻醇提取物可以有效降低高脂高糖饮食大鼠的血脂水平,对其肝脏具有保护作用。泽泻醇提取物也能通过改变肠道菌群的丰度、多样性和功能类群等靶标进行脂质代谢调节。     

Effects of supplementing different chromium histidinate complexes on glucose and lipid metabolism and related protein expressions in rats fed a high-fat diet

BackgroundThe objective of this study was to investigate the effects of different chromium histidinate (CrHis) complexes added to the diet of rats fed a high-fat diet (HFD) on body weight changes, glucose and lipid metabolism parameters, and changes in biomarkers such as PPAR-γ, IRS-1, GLUTs, and NF-κB proteins.MethodsForty-two Sprague–Dawley rats were divided equally into six groups and fed either a control, an HFD, or an HFD supplemented with either CrHis1, CrHis2, CrHis3, or a combination of the CrHis complexes as CrHisM.ResultsFeeding an HFD to rats increased body weights, HOMA-IR values, fasting serum glucose, insulin, leptin, free fatty acid, total cholesterol, low-density lipoprotein cholesterol, and MDA concentrations as well as AST activities, and decreased serum and brain serotonin concentrations compared with rats fed a control diet (P < 0.0001). The levels of the PPAR-γ, IRS-1, and GLUTs in the liver and brain decreased, while NF-κB level increased, with feeding an HFD (P < 0.05). Although all the CrHis supplements reversed the negative effects of feeding an HFD (P < 0.05), the CrHis1 complex was most effective in changing the protein levels, while CrHisM was most effective in influencing certain parameters such as body weight and serum metabolites.ConclusionThe results of the present work suggest that the CrHis1 complex is most potent for alleviating the negative effects of feeding an HFD. The efficacy of CrHisM is likely due to the presence of the CrHis1 complex.     

Effect of green tea on hepatic lipid metabolism in mice fed a high-fat diet

Green tea (GT) is a widely consumed beverage with health benefits, including antiobesity effects; however, the efficacy of GT on lipid levels associated with obesity is not clearly understood. Here, we examined the impact of GT consumption on lipid metabolism in the livers of high-fat diet (HFD)-induced obese mice. We performed lipid profiling using ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry in C57BL/6J mice fed a normal diet (ND), HFD and HFD with GT for 12 weeks. The partial least squares discriminant analysis score plot showed a difference among the groups and revealed that the levels of several lipid metabolites were altered in mice fed HFD with GT. The decreased levels of lysophospholipids (LPLs), such as lysophosphatidylcholine, lysophosphatidylethanolamine and lysophosphatidylserine, in HFD mice compared to those of the ND group were recovered by supplementation of GT. In agreement with these lipid metabolites changes, hepatic lysophosphatidylcholine acyltransferase 2/4 was significantly increased in HFD mice. This study showed abnormal changes in lipid species associated with obesity, and these levels were attenuated by GT intake, suggesting a relationship between the reduction of hepatic LPL levels and inflammation in obesity.     

Effect of caffeine on the body fat and lipid metabolism of rats fed on a high-fat diet

The intake of caffeine (CF) at 0.025, 0.05 or 0.1% for 21 days progressively reduced the body fat mass and body fat percentage in Sprague-Dawley (SD) rats fed on a high-fat diet with increasing administration level. Moreover, CF increased the serum concentrations of catecholamines and free fatty acids in SD rats orally administered with CF (5 mg/kg). These results suggest that the intake of CF reduced body fat by lipolysis via catecholamines. CF has potential as a functional food ingredient with an anti-obesity action.     

Moringa peregrina leaf extracts produce anti-obesity,hypoglycemic, anti-hyperlipidemic,and hepatoprotective effects on high-fat diet fed rats

This present research investigated the anti-obesity and hepatoprotective effects of ethanolic Moringa peregrina leaf (MPLE) and bark extracts (MPBE), in the rats fed with a high-fat diet (HFD). Healthy male rats (n = 48) were randomly distributed to six groups (n = 8): control AIN-93 diet; HFD; HFD + MPBE bark extracts ((300 mg/kg); HFD + MPBE (600 mg/kg); HFD + MPLE (300 mg/kg); HFD + MPLE (600 mg/kg). HFD-fed rats in the Moringa peregrina (MP) treatment groups received orally administered MP leaf or bark extract daily for eight weeks. The results revealed that both doses of MP leaf extract significantly reduced HFD-induced increases in their food intake and the gained body weight, fat pad weights (visceral, subcutaneous, and epididymal), glucose and insulin plasma levels, and leptin and resistin serum levels in HFD-fed rats. Concomitantly, MP leaf extract improved glucose levels after oral or intraperitoneal glucose tolerance tests, reduced serum cholesterol, triglycerides, and the low-density lipoprotein LDL concentration, reduced hepatic triglycerides and cholesterol levels, and increased serum high-density lipoproteins HDL levels and triglycerides and cholesterol levels in fecal. Moreover, the administration of MPLE to HFD-fed rats improved liver architecture, reduced fat accumulation, reduced hepatic malondialdehyde, tumor necrosis factor-α, and interleukin-6 levels. Hepatic glutathione peroxidase, superoxide dismutase, and catalase activities were significantly increased. All observed effects were more pronounced in HFD-fed rats treated with a 600 mg/kg MP dose. However, neither dose of MPBE altered the measured markers in the HFD-fed rats. In conclusion, MPLE showed potential anti-obesity and hepatoprotective activity in HFD-induced obese rats, mediated by reduced lipid absorption, anti-hyperlipidemic effects, and hepatic antioxidant effects.     

双歧杆菌制剂对大鼠肝硬化模型的影响

目的探讨肠道环境改变与大鼠肝硬化的关系.方法 90只雄性SD大鼠随机分为正常对照组、预防组、晚期治疗组和模型组.预防组和晚期治疗组分别从不同时期开始给予喂服双歧杆菌制剂.实验第11周末处死所有大鼠,HE染色观察肝脏病理改变,测定血清转氨酶(ACT)、白蛋白水平及血浆内毒素、一氧化氮(NO)含量.结果预防组肝硬化病变程度轻,晚期治疗组病变程度介于模型组和预防组之间.预防组、晚期治疗组血清ALT和血浆内毒素、NO水平明显低于模型组(P＜0.05～001),白蛋白水平高于模型组(P＜0.05).结论双歧杆菌制剂通过改变肠道环境,对肝硬化病变起到了稳定和缓解作用,提示肠道细菌过度生长等肠道环境改变是肝硬化病变发展的重要机制之一.